Masahide Mori - Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center

基本信息

浏览量：72

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 160 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer with EGFR Exon 19 Insertions: Clinical-Genomic, Preclinical Analysis Through LC-SCRUM-Asia (Multi-Institutional Genomic Screening Registry)

Yuji Uehara,Hiroki Izumi, Ikei S Kobayashi,Shingo Matsumoto,Yukio Hosomi,Takae Okuno,Jun Sugisaka,Naoto Takase,Kageaki Taima,Shinichi Sasaki,Shuhei Teranishi,Shingo Miyamoto,Masahide Mori,Chiho Nakashima, Shuichi Asano, Hajime Oi,Tetsuya Sakai, Yuji Shibata,Hibiki Udagawa,Eri Sugiyama,Kaname Nosaki,Shigeki Umemura,Yoshitaka Zenke,Kiyotaka Yoh,Sadakatsu Ikeda,Daniel B Costa, Susumu S Kobayashi,Koichi Goto

Lung cancer (Amsterdam, Netherlands) (2025): 108479-108479

引用0浏览0WOS引用

Stage-specific Efficacy of Osimertinib in Treatment-Naïve EGFR-mutant Non-Small Cell Lung Cancer According to Baseline Genetic Alterations in Circulating Tumor DNA

Yoshihiko Taniguchi,Akihiro Tamiya,Mitsuo Osuga,Shun-ichi Isa,Keiichi Nakamura,Yasuyuki Mizumori, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi,Masahide Oki,Masahide Mori,Tomohito Kuwako,Koji Yamazaki, Masahiro Shimada,Masahiko Ando,Yasuhiro Koh

Investigational New Drugspp.1-7, (2025)

引用0浏览0WOS引用

Skin Disorder Within 30 Days is a Favorable Prognostic Factor in Patients with Lung Squamous Cell Carcinoma Treated with Necitumumab Plus Gemcitabine and Cisplatin: a Sub-Analysis of the NINJA Study

Fumihiko Kinoshita,Shigeru Tanzawa,Toshihiro Misumi,Hiroshige Yoshioka,Eisaku Miyauchi,Kiichiro Ninomiya,Yasunori Murata,Masafumi Takeshita,Masafumi Yamaguchi,Shunichi Sugawara,Yosuke Kawashima, Kazuki Hashimoto,Masahide Mori,Akihiko Miyanaga, Anna Hayashi,Hisashi Tanaka, Ryoichi Honda,Masafumi Nojiri,Yuki Sato, Ken Yamamoto,Ken Masuda,Toshiyuki Kozuki,Takahisa Kawamura,Takuji Suzuki,Teppei Yamaguchi,Kazuhiro Asada,Satoshi Tetsumoto,Hiroshi Tanaka,Satoshi Watanabe,Yukihiro Umeda,Kakuhiro Yamaguchi,Shoichi Kuyama,Kosuke Tsuruno,Yuki Misumi,Hiroshi Kuraishi, Ken Yoshihara,Akira Nakao,Akihito Kubo, Toshihiko Yokoyama,Kana Watanabe,Nobuhiko Seki

Therapeutic advances in medical oncology (2025): 17588359241312503-17588359241312503

引用0浏览0WOS引用

Serum VEGF-A As a Biomarker for the Addition of Bevacizumab to Chemo-Immunotherapy in Metastatic NSCLC

Kentaro Tanaka,Jun Sugisaka,Yoshimasa Shiraishi, Yasutaka Watanabe,Haruko Daga,Koichi Azuma,Kazumi Nishino,Masahide Mori,Takayo Ota,Haruhiro Saito,Akito Hata, Tadashi Sakaguchi,Toshiyuki Kozuki,Hiroaki Akamatsu,Hirotaka Matsumoto,Motoko Tachihara,Kazushige Wakuda,Yuki Sato, Tomohiro Ozaki, Yuko Tsuchiya-Kawano,Nobuyuki Yamamoto,Kazuhiko Nakagawa,Isamu Okamoto

Nature communicationsno. 1 (2025): 2825-2825

引用0浏览0WOSNATURE引用

Real-World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in Japan

Satoshi Miyamoto, Akihiro Tsukaguchi,Hanako Kuhara,Taiichiro Otsuki,Takayuki Shiroyama,Motohiro Tamiya,Akihiro Tamiya,Kazumi Nishino,Yoshito Takeda,Takashi Kijima,Meinoshin Okumura,Atsushi Kumanogoh,Masahide Mori

Thoracic cancerno. 6 (2025): e70047-e70047

引用0浏览0WOS引用

NHERF2 As a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles

International journal of molecular sciencesno. 3 (2025)

引用0浏览0WOS引用

Clinical Impact of Hypomagnesemia Induced by Necitumumab Plus Cisplatin and Gemcitabine Treatment in Patients with Advanced Lung Squamous Cell Carcinoma: a Subanalysis of the NINJA Study

Therapeutic advances in medical oncology (2025): 17588359251318850-17588359251318850

引用0浏览0WOS引用

Impact of Serum Eicosapentaenoic Acid/arachidonic Acid Ratio on Overall Survival in Lung Cancer Patients Treated with Pembrolizumab: a Pilot Study

Ikue Tanaka,Yukihiro Yano,Masahide Mori,Satoru Manabe,Keisuke Fukuo

SCIENTIFIC REPORTSno. 1 (2024)

引用1浏览0WOSNATURE引用

Mechanisms of Resistance and Correlation Between Pre-Treatment Co-Alterations and P-Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung Cancer

Akihiro Tamiya,Mitsuo Osuga,Daijiro Harada,Shun-ichi Isa,Yoshihiko Taniguchi,Keiichi Nakamura,Yasuyuki Mizumori, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi,Masahide Oki,Masahide Mori,Tomohito Kuwako,Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

Lung Cancer (2024): 107917-107917

引用0浏览0WOS引用

Baseline Genetic Abnormalities and Effectiveness of Osimertinib Treatment in Patients with Chemotherapy-Naïve EGFR-mutated NSCLC Based on Performance Status

Yoshihiko Taniguchi,Akihiro Tamiya,Mitsuo Osuga,Daijiro Harada,Shun-ichi Isa,Keiichi Nakamura,Yasuyuki Mizumori, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi,Masahide Oki,Masahide Mori,Tomohito Kuwako,Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

BMC Pulmonary Medicine（2024）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn